Anirban Maitra: What’s Next for Early-Phase Drug Development and Rare Cancer Research at NYU Langone?
Anirban Maitra/LinkedIn

Anirban Maitra: What’s Next for Early-Phase Drug Development and Rare Cancer Research at NYU Langone?

Anirban Maitra, Professor of Pathology and Medicine at NYU Langone Health, shared on LinkedIn:

“Beyond excited to recruit Vivek Subbiah, MD to NYU Langone Health Perlmutter Cancer Center as director of the Early Phase Drug Development Program and the Rare Cancer Program.

Welcome to NYC Vivek! NYU Grossman School of Medicine John Leonard.”

Read more.”

Other articles featuring Anirban Maitra on OncoDaily.